Capital Flow Monitor · Sponsors · CIK 1752026
Linnaeus Therapeutics, Inc.
30 WASHINGTON AVENUE, SUITE F, HADDONFIELD, NJ, 08033 · 856-433-1500
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$10.0M
Sold
$5.0M
% sold
49.9%
Investors
26
Min investment
$1
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-02 | D/A ·current | 506(b) | $10.0M | $5.0M | 49.9% | 26 | EDGAR ↗ |
| 2026-03-31 | D/A | 506(b) | $10.0M | $4.9M | 48.9% | 26 | EDGAR ↗ |
| 2026-03-13 | D/A | 506(b) | $10.0M | $4.8M | 47.9% | 25 | EDGAR ↗ |
| 2026-02-27 | D | 506(b) | $10.0M | $4.5M | 44.8% | 19 | EDGAR ↗ |
| 2025-08-22 | D | 506(c) | $10.0M | $1.3M | 12.8% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Patrick Mooney — Executive Officer / Director, Haddonfield, NJ
-
James Demetriades — Director, Haddonfield, NJ
1 other raise
- Provivi, Inc. $25.5M of $40.0M · 63.7%
- Michael Poisel — Director, Haddonfield, NJ
- Chris Arendt — Director, Haddonfield, NJ
-
Todd Thomson — Director, Haddonfield, NJ
3 other raises
- SCN Canada, Inc. $50K of —
- ZOOZ Power Ltd. $151.0M of $151.0M · 100.0%
- ACTUATE THERAPEUTICS, INC. $4.7M of $9.3M · 50.0%
- John Lepping — Director, Haddonfield, NJ
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.